Open AccessTHE EFFECTIVENESS OF RENALOF® COMPARED TO KALKURENAL® AND PLACEBO
Author(s) -
Benny Kristyantoro,
Sabilal Alif,
Tarmono Djojodimedjo,
Budiono Budiono
Publication year - 2012
Publication title -
jurnal urologi indonesia (indonesian journal of urology)
Language(s) - English
Resource type - Journals
ISSN - 2355-1402
DOI - 10.32421/juri.v19i2.61
Subject(s) - placebo , uric acid , medicine , excretion , urology , renal stone , urine , kidney stones , calcium , placebo group , urinary system , calculus (dental) , surgery , dentistry , pathology , alternative medicine
Objective: To compare the effectiveness after administration of Renalof to Kalkurenal and placebo in patient with renal calculus. Material & Method: We analyzed 30 patient with renal calculi less than or equal to 20 mm (2 cm) between January 2011 and March 2011. Patients were divided into 3 groups. Nine patients were treated with placebo, 8 patients were treated with Kalkurenal and the last 13 patients were treated with Renalof. After 30 days, we analyzed calcium and uric acid excretion for 24 hours and measured the stone with plain abdominal film and renal ultrasound. Results: There were decreased in excretion of calcium and uric acid all of patients but not significant statistically (p > 0,05) and there were significant decreased on stone measurement in patient treated with Renalof. Conclusion: Renalof can be given as adjunct therapy for patient with renal calculi.
Keywords: Calcium and uric acid excretion in urine 24 hours, stone measurement and stone surface area.